resveratrol formulation srt501

Drug Overview

Resveratrol formulation SRT501 is a specialized, high-potency version of a natural compound found in red wine and grapes. While many people know resveratrol as a supplement, SRT501 was engineered as a “Smart Drug” to be absorbed by the body much better than standard versions. It is classified as a Targeted Therapy because it focuses on specific proteins that control how cells age and handle stress.

In the corporate medical world, SRT501 is recognized for its “micronized” design—the particles are made very small so they can enter the bloodstream more effectively. For patients, this represents a bridge between natural compounds and high-tech medicine. It is primarily studied for its ability to protect healthy cells while potentially stopping cancer cells from dividing.

• Generic Name: Resveratrol formulation SRT501
• US Brand Names: None (Currently an investigational drug)
• Drug Class: Sirtuin 1 (SIRT1) Activator; Antioxidant
• Route of Administration: Oral (Liquid suspension or powder)
• FDA Approval Status: Investigational (Not currently FDA approved for general use)

What Is It and How Does It Work? (Mechanism of Action)

To understand how SRT501 works, imagine your cells have a “repair crew” that fixes broken DNA and cleans up cellular waste. This crew is led by a protein called SIRT1. As we get sick or age, the crew becomes lazy. SRT501 acts like a high-energy supervisor that wakes up the SIRT1 protein to get the repair crew back to work.

At the molecular level, SRT501 operates through several sophisticated pathways:

1. SIRT1 Activation: SRT501 binds directly to the SIRT1 enzyme. This activation helps protect cells from “oxidative stress” (damage from unstable molecules). It also improves how the cell uses energy through the mitochondria (the cell’s power plants).
2. Inhibition of NF-κB: Inflammation is like a fire that helps cancer grow. SRT501 blocks a signaling “switch” called NF-κB. By flipping this switch off, the drug reduces the inflammation that tumors use to survive and spread.
3. AMPK Pathway: SRT501 also triggers the AMPK pathway, which regulates metabolism. In cancer cells, this can starve the tumor of the sugar it needs to grow, while in healthy cells, it provides more steady energy.
4. Apoptosis Induction: In specific cancer cells, SRT501 can trigger “programmed cell death” or apoptosis. It does this by affecting the p53 protein, which is the body’s natural internal security guard against cancer.

FDA-Approved Clinical Indications

As an investigational agent, SRT501 is not yet approved by the FDA for any specific disease. However, it has been used in clinical research for the following:

Oncological Uses (Investigational)

• Multiple Myeloma: Studied in combination with standard treatments like bortezomib.
• Colorectal Cancer: Researched for its ability to reduce tumor cell growth before surgery.
• Advanced Solid Tumors: Investigated for patients who have not responded to other therapies.

Non-Oncological Uses

• Type 2 Diabetes: Studied for its potential to lower blood sugar and improve insulin sensitivity.
• Metabolic Disorders: Research into how it helps the body process fats and sugars.

Dosage and Administration Protocols

SRT501 is taken as an oral liquid. Because it is a micronized formulation, it must be measured carefully according to clinical trial guidelines.

Dose Adjustments:

• Renal (Kidney) Insufficiency: CRITICAL: Research was halted in some cases due to kidney concerns. Patients with pre-existing kidney disease are usually excluded or given very low doses under strict monitoring.
• Hepatic (Liver) Insufficiency: No standard adjustment is established, but liver enzymes are checked frequently.

Clinical Efficacy and Research Results

Recent clinical data from the 2020-2025 period focuses on why SRT501 is a complex drug to study.

• Multiple Myeloma Results: In Phase II trials, SRT501 showed some activity in slowing down cancer progression. However, researchers noted that its effectiveness was limited by side effects in certain patient groups.
• Bioavailability: Numerical data confirms that the SRT501 formulation increases resveratrol levels in the blood by 5 to 8 times more than standard resveratrol supplements.
• Disease Progression: In colorectal cancer studies, patients taking SRT501 for 14 days before surgery showed a measurable increase in “cleaved caspase-3” in their tumors, which is a marker that the cancer cells were starting to die.

Safety Profile and Side Effects

Black Box Warning:

None. (However, there is a major safety concern regarding Acute Renal Failure in patients with Multiple Myeloma).

Common Side Effects (>10%)

• Diarrhea: The most frequent side effect, often mild to moderate.
• Nausea: General stomach upset after taking the dose.
• Abdominal Cramping: Digestive discomfort.
• Fatigue: Feeling unusually tired.

Serious Adverse Events

• Kidney Dysfunction: High doses can lead to “cast nephropathy,” especially in patients already at risk.
• Dehydration: Usually caused by severe diarrhea.

Management Strategies

• Hydration: Patients are encouraged to drink at least 8 glasses of water a day to protect the kidneys.
• Symptom Reporting: Any decrease in urine output or sudden weight gain (swelling) must be reported to a doctor immediately.

Research Areas

In the fields of Immunotherapy and Regenerative Medicine, SRT501 is being studied for its role in “Cellular Longevity.” Scientists are investigating how SRT501 can help Mesenchymal Stem Cells (MSCs) stay healthy longer, which could improve the body’s ability to regenerate bone and tissue. Current research is also looking at whether SRT501 can be used alongside Checkpoint Inhibitors to help the immune system “wither” the defense of tumors more effectively.

Patient Management and Practical Recommendations

Pre-treatment Tests to be Performed

• Creatinine and BUN Tests: To ensure kidneys are working perfectly.
• Baseline Blood Count: To check overall health.
• Liver Enzyme Panel.

Precautions During Treatment

• Avoid Other Supplements: Do not take other resveratrol products, as this can lead to toxic levels.
• Monitor Urine: Keep track of how much you are urinating each day.

“Do’s and Don’ts” List

• Do take the dose at the same time every day for the best results.
• Do tell your doctor about all other medications, especially blood thinners.
• Don’t take this drug if you have a history of kidney problems.
• Don’t assume that “natural” means it cannot have serious side effects.

Legal Disclaimer

Standard medical information disclaimer: This guide is for informational purposes only and does not constitute medical advice. Resveratrol formulation SRT501 is an investigational drug and is not currently approved by the FDA for the treatment of cancer or any other condition. Always consult with a licensed oncologist or healthcare professional before participating in a clinical trial or starting a new treatment. This content reflects research data available as of early 2026.